Department of Chemistry, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603203, India.
Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
J Photochem Photobiol B. 2023 Nov;248:112796. doi: 10.1016/j.jphotobiol.2023.112796. Epub 2023 Oct 4.
This comprehensive review provides the current trends and recent developments of porphyrin-based photosensitizers. We discuss their evolution from first-generation to third-generation compounds, including cutting-edge nanoparticle-integrated derivatives, and explores their pivotal role in advancing photodynamic therapy (PDT) for enhanced cancer treatment. Integrating porphyrins with nanoparticles represents a promising avenue, offering improved selectivity, reduced toxicity, and heightened biocompatibility. By elucidating recent breakthroughs, innovative methodologies, and emerging applications, this review provides a panoramic snapshot of the dynamic field, addressing challenges and charting prospects. With a focus on harnessing reactive oxygen species (ROS) through light activation, PDT serves as a minimally invasive therapeutic approach. This article offers a valuable resource for researchers, clinicians, and PDT enthusiasts, highlighting the potential of porphyrin photosensitizers to improve the future of cancer therapy.
这篇全面的综述提供了基于卟啉的光敏剂的当前趋势和最新进展。我们讨论了它们从第一代到第三代化合物的演变,包括最先进的纳米颗粒整合衍生物,并探讨了它们在推进光动力疗法(PDT)以增强癌症治疗方面的关键作用。将卟啉与纳米颗粒结合代表了一种有前途的途径,提供了更高的选择性、降低的毒性和提高的生物相容性。通过阐明最近的突破、创新方法和新兴应用,本综述提供了对动态领域的全景快照,解决了挑战并规划了前景。通过利用光激活产生的活性氧物质 (ROS),PDT 作为一种微创治疗方法。本文为研究人员、临床医生和 PDT 爱好者提供了有价值的资源,强调了卟啉光敏剂在改善癌症治疗未来方面的潜力。